{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:22:37Z","timestamp":1786998157976,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.xcrm.2024.101587","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T10:38:55Z","timestamp":1716374335000},"page":"101587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Vaccination with nanoparticles displaying gH\/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus"],"prefix":"10.1016","volume":"5","author":[{"given":"Kristina R.","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah J.","family":"Homad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gargi M.","family":"Kher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen A.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana","family":"Ben-Akiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Prlic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan W.","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell J.","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Pancera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1841-6859","authenticated-orcid":false,"given":"Andrew T.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101587_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein\u2013Barr Virus Infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101587_bib2","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","article-title":"Age-Specific Prevalence of Epstein\u2013Barr Virus Infection Among Individuals Aged 6\u201319 Years in the United States and Factors Affecting Its Acquisition","volume":"208","author":"Balfour","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101587_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1073\/pnas.59.1.94","article-title":"Relation of Burkitt\u2019s tumor-associated herpes-ytpe virus to infectious mononucleosis","volume":"59","author":"Henle","year":"1968","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101587_bib4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101587_bib5","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","article-title":"Epstein\u2013Barr Virus in Burkitt\u2019s Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx","volume":"228","author":"Hausen","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101587_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","article-title":"Detection\u00a0of Epstein\u2013Barr Viral Genomes in Reed\u2013Sternberg Cells of Hodgkin\u2019s Disease","volume":"320","author":"Weiss","year":"1989","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2024.101587_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037505","article-title":"Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990-2017","volume":"10","author":"Khan","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.xcrm.2024.101587_bib8","series-title":"The Global Landscape of EBV-Associated Tumors","author":"Shannon-Lowe","year":"2019"},{"key":"10.1016\/j.xcrm.2024.101587_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00432-021-03824-y","article-title":"Estimating the global burden of Epstein-Barr virus-related cancers","volume":"148","author":"Wong","year":"2022","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101587_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","article-title":"The immunology of Epstein-Barr virus-induced disease","volume":"33","author":"Taylor","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2024.101587_bib11","series-title":"Epstein-Barr Virus and Rheumatoid Arthritis","author":"Balandraud","year":"2018"},{"key":"10.1016\/j.xcrm.2024.101587_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101587_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12026-014-8584-2","article-title":"ACPA-positive RA patients, antibodies to EBNA35-58Cit, a citrullinated peptide from the Epstein\u2013Barr nuclear antigen-1, strongly cross-react with the peptide \u03b260-74Cit which bears the immunodominant epitope of citrullinated fibrin","volume":"61","author":"Cornillet","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.xcrm.2024.101587_bib14","doi-asserted-by":"crossref","first-page":"e12496","DOI":"10.1371\/journal.pone.0012496","article-title":"An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis","volume":"5","author":"Handel","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101587_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","article-title":"Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM","volume":"603","author":"Lanz","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101587_bib16","article-title":"Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2024.101587_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijid.2020.12.051","article-title":"EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count","volume":"104","author":"Paolucci","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101587_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","article-title":"High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19","volume":"51","author":"Simonnet","year":"2021","journal-title":"Infect. Dis. Now"},{"key":"10.1016\/j.xcrm.2024.101587_bib19","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101587_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens10060763","article-title":"Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation","volume":"10","author":"Gold","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.xcrm.2024.101587_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ijc.2910350107","article-title":"A re-examination of the epstein-barr virus carrier state in healthy seropositive individuals","volume":"35","author":"Yao","year":"1985","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2024.101587_bib22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of Protection Induced by Vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.xcrm.2024.101587_bib23","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","article-title":"Evidence for antibody as a protective correlate for COVID-19 vaccines","volume":"39","author":"Earle","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2024.101587_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/viro.2001.1141","article-title":"Different Functional Domains in the Cytoplasmic Tail of Glycoprotein B Are Involved in Epstein\u2013Barr Virus-Induced Membrane Fusion","volume":"290","author":"Haan","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2024.101587_bib25","doi-asserted-by":"crossref","first-page":"9444","DOI":"10.1128\/JVI.00572-06","article-title":"Soluble Epstein-Barr Virus Glycoproteins gH, gL, and gp42 Form a 1:1:1 Stable Complex That Acts Like Soluble gp42 in B-Cell Fusion but Not in Epithelial Cell Fusion","volume":"80","author":"Kirschner","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2024.101587_bib26","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.immuni.2019.03.010","article-title":"Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells","volume":"50","author":"Bu","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2024.101587_bib27","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.immuni.2022.10.003","article-title":"Epstein-Barr virus gH\/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition","volume":"55","author":"Chen","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2024.101587_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.immuni.2018.03.026","article-title":"An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus","volume":"48","author":"Snijder","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2024.101587_bib29","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1038\/s41467-021-26912-6","article-title":"A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101587_bib30","article-title":"Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus","volume":"1","author":"Singh","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2024.101587_bib31","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1126\/science.276.5321.2030","article-title":"An Animal Model for Acute and Persistent Epstein-Barr Virus Infection","volume":"276","author":"Moghaddam","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101587_bib32","first-page":"57","article-title":"Comparative pathobiology of macaque lymphocryptoviruses","volume":"58","author":"Carville","year":"2008","journal-title":"Comp. Med."},{"key":"10.1016\/j.xcrm.2024.101587_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/JVI.76.1.421-426.2002","article-title":"Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model","volume":"76","author":"Rivailler","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2024.101587_bib34","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1182\/blood-2004-01-0342","article-title":"Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host","volume":"104","author":"Rivailler","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2024.101587_bib35","first-page":"385","article-title":"Non-human Primate Lymphocryptoviruses: Past, Present, and Future","volume":"391","author":"M\u00fche","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.xcrm.2024.101587_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002308","article-title":"Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge","volume":"7","author":"Sashihara","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2024.101587_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/vaccines9030285","article-title":"Immunization with Epstein\u2013Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge","volume":"9","author":"Cui","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.xcrm.2024.101587_bib38","article-title":"Immunization with a self-assembling nanoparticle vaccine displaying EBV gH\/gL protects humanized mice against lethal viral challenge","volume":"3","author":"Malhi","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2024.101587_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf3685","article-title":"A bivalent Epstein-Barr virus vaccine induces neutralizing antibodies that block infection and confer immunity in humanized mice","volume":"14","author":"Wei","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2024.101587_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf1152","article-title":"A particulate saponin\/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity","volume":"6","author":"Silva","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2024.101587_bib41","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1128\/JCM.38.9.3219-3225.2000","article-title":"Cloning of the rhesus lymphocryptovirus viral capsid antigen and Epstein-Barr virus-encoded small RNA homologues and use in diagnosis of acute and persistent infections","volume":"38","author":"Rao","year":"2000","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.xcrm.2024.101587_bib42","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101587_bib43","article-title":"Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model","volume":"2","author":"M\u00fche","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2024.101587_bib44","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1099\/vir.0.82949-0","article-title":"Compatibility of the gH homologues of Epstein\u2013Barr virus and related lymphocryptoviruses","volume":"88","author":"Wu","year":"2007","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.xcrm.2024.101587_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.virol.2007.03.054","article-title":"Functional homology of gHs\u00a0and gLs from EBV-related \u03b3-herpesviruses for EBV-induced membrane fusion","volume":"365","author":"Omerovi\u0107","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2024.101587_bib46","series-title":"Methods in Molecular Biology","first-page":"187","article-title":"Analysis of Fusion Using a Virus-Free Cell Fusion Assay","author":"McShane","year":"2005"},{"key":"10.1016\/j.xcrm.2024.101587_bib47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.immuni.2018.07.009","article-title":"Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization","volume":"49","author":"Bianchi","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2024.101587_bib48","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells","volume":"74","author":"Molesworth","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2024.101587_bib49","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/jvi.62.4.1108-1114.1988","article-title":"Induction of antibodies to the Epstein-Barr virus glycoprotein gp85 with a synthetic peptide corresponding to a sequence in the BXLF2 open reading frame","volume":"62","author":"Oba","year":"1988","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2024.101587_bib50","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection","volume":"15","author":"Rickinson","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2024.101587_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007464","article-title":"Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T\u00a0cells\u00a0and offer increased protection against EBV infection ex\u00a0vivo and in mice","volume":"14","author":"van Zyl","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2024.101587_bib52","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.immuni.2019.04.011","article-title":"T Follicular Helper Cell Biology: A Decade of Discovery and Diseases","volume":"50","author":"Crotty","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2024.101587_bib53","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.95.14.8245","article-title":"Propagation and recovery of intact, infectious Epstein\u2013Barr virus from prokaryotic to human cells","volume":"95","author":"Delecluse","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101587_bib54","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/356347a0","article-title":"Epstein\u2013Barr virus infection and replication in a human epithelial cell system","volume":"356","author":"Li","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2024.101587_bib55","doi-asserted-by":"crossref","first-page":"7678","DOI":"10.1128\/JVI.00457-09","article-title":"Functional Analysis of Glycoprotein L (gL) from Rhesus Lymphocryptovirus in Epstein-Barr Virus-Mediated Cell Fusion Indicates a Direct Role of gL in gB-Induced Membrane Fusion","volume":"83","author":"Plate","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2024.101587_bib56","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/viro.1998.9530","article-title":"Host Range of Human T-Cell Leukemia Virus Type I Analyzed by a Cell Fusion-Dependent Reporter Gene Activation Assay","volume":"254","author":"Okuma","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2024.101587_bib57","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1073\/pnas.232381299","article-title":"Glycoprotein gp110 of Epstein\u2013Barr virus determines viral tropism and efficiency of infection","volume":"99","author":"Neuhierl","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101587_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jsb.2005.03.010","article-title":"Automated molecular microscopy: the new Leginon system","volume":"151","author":"Suloway","year":"2005","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1016\/j.xcrm.2024.101587_bib59","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.chom.2010.11.004","article-title":"An ATM\/Chk2-Mediated DNA Damage-Responsive Signaling Pathway Suppresses Epstein-Barr Virus Transformation of Primary Human B Cells","volume":"8","author":"Nikitin","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2024.101587_bib60","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2009.06.013","article-title":"Human antibody titers to Epstein\u2013Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay","volume":"391","author":"Sashihara","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2024.101587_bib61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124002799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124002799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T11:16:08Z","timestamp":1718709368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124002799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2666379124002799"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101587","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination with nanoparticles displaying gH\/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101587","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101587"}}